The company, which became fully independent in June 2013 after completing its separation from Pfizer, hosted the event this morning at the Hilton Short Hills Hotel, in Short Hills, New Jersey.

Zoetis Chairman, Michael McCallister, presided over the business portion of the meeting and shareholder voting. He was joined by Zoetis Chief Executive Officer, Juan Ramón Alaix, who discussed the company’s first year as an independent company, the core strengths of its business model, and its long-term value proposition for shareholders.

A full replay of the meeting is available at http://investor.zoetis.com/events-presentations, along with a copy of Mr Alaix’s prepared remarks and presentation.

Preliminary results from the Annual Meeting of Shareholders indicate the following results of shareholder voting:

• Gregory Norden, Louise M. Parent and Robert W. Scully have been elected as directors for three-year terms.
• Shareholders ratified and approved the selection of KPMG LLP as the company’s independent registered public accounting firm for the 2014 fiscal year.
• Shareholders voted to approve, on an advisory basis, the compensation of the company’s named executive officers, and to approve the holding of an advisory vote on executive compensation every year. In addition, shareholders voted to approve the company’s 2013 Equity and Incentive Plan.

The final results of the shareholder voting are subject to verification by the independent election inspectors and will be filed in a Form 8-K and available on the company’s web site.